Stage 2 Hypertension Completed Phase 4 Trials for Valsartan (DB00177)

IndicationStatusPhase
DBCOND0042488 (Stage 2 Hypertension)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT008099268 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 HypertensionTreatment